Angioimmunoblastic
T-Cell Lymphoma
Long-Term Survivorship
Once treatment is completed and AITL is in remission, physicians will continue to monitor the health and status of each patient during follow-up care. Patients in remission should have regular visits with a physician who is familiar with their medical history and the treatments they have received.
Some treatments can cause long-term effects or late effects, which can vary based on duration and frequency of treatments, age, gender and the overall health of each patient at the time of treatment. A physician will check for these effects during follow-up care. Visits may become less frequent the longer the disease remains in remission.
Learn More
To learn more about long-term survivorship, view the Lymphoma Survivorship Guide Series. Want to talk to someone? For answers to lymphoma-related questions and resources, contact our Lymphoma Resource Center at (800) 500-9976 or [email protected].
Additional Resources
To learn more about AITL, view the T-Cell Lymphomas Guide.
Events
Events
-
-
Ask the Doctor About Lymphoma: Navigating Relapsed/Refractory Disease
Ask the Doctor About Lymphoma is a virtual two-hour program that combines a comprehensive and […]
-
Understanding and Accessing Chimeric Antigen Receptor (CAR) T-Cell Therapy Webinar
Webinars are hour-long interactive programs discussing the diagnosis and treatment of specific lymphoma subtypes and […]
-
-
Supporting a Loved One with Lymphoma: A Webinar for Care Partners
Program Overview This program is hosted virtually on Zoom and can be accessed online and […]